Work

Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz283.029

Authors: S. Bauer, J.H. Lewis, H. Gelderblom, M. van de Sande, S. Stacchiotti, J.H. Healey, W.D. Tap, A.J. Wagner, A Lopez Pousa, M. Druta, C.-C. Lin, H.A. Baba, A. Yver, D.E. Shuster, J. McGill, X. Gu, L.D. DeLeve

Institutions: Essen University Hospital, University of Duisburg-Essen, Georgetown University, Georgetown University Medical Center, Leiden University Medical Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Hospital de Sant Pau, Moffitt Cancer Center, National Taiwan University Hospital, Daiichi Sankyo (United States), University of Southern California

Language: English

Topic: Musculoskeletal synovial abnormalities and treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2977282153

FWCI: 0.655

Cites:

Cited by: 5

Related to: 10